GRDN
Guardian Pharmacy Services, Inc.Data: 2026-10-22
Quick Stats
Oct 22, 202660.2
AI Score
HOLD0.4
Volume Ratio
Nov 09, 2026
Next Earnings
11
+ve Days (30d)
19
-ve Days (30d)
GRDN Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
GRDN Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
GRDN Options - Sort by Max open Interest (near term)
22nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GRDN Daily Out of Money Options - Sort by Max open Interest (near term)
22nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GRDN Daily In the Money Options - Sort by Max open Interest (near term)
22nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GRDN Most Active Options by Volume(near term)
22nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
GRDN Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
GRDN Stock Summary
Last updated Oct 22, 2026
GRDN is currently trading at $39.59, positioned above its 200-day moving average of $37.81, indicating a long-term uptrend. The stock has a 52-week range of $26.3401 to $48.33.
Technical Analysis: The 50-day moving average stands at $40.83, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 44.414, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.015, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates GRDN at 60.2/100 with a HOLD recommendation.
GRDN (Guardian Pharmacy Services, Inc.) Indicators
Last updated Oct 22, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 44.414 |
| CMF (20) | 0.015 |
| ROC (10) | -4.832 |
| ADX (14) | 14.227 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.533 |
| AROONOSC (14) | -78.571 |
| WILLAMS %R (14) | -83.168 |
| MFI (14) | 39.188 |
GRDN Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Oct 14 | Piercing Line (contrarian — textbook says the opposite) | Bearish | 50.5% | +3.5 pts | 4474 |
| Oct 12 | Three Inside Down (contrarian — textbook says the opposite) | Bullish | 56.9% | +3.9 pts | 8868 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
Guardian Pharmacy Services, Inc. is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).
GRDN Moving Averages Analysis
Guardian Pharmacy Services, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Oct 22, 2026
GRDN (Guardian Pharmacy Services, Inc.) Simple Moving Averages
Moving Averages are last updated Oct 22, 2026
| Days | MA |
|---|---|
| 10 | 40.19 |
| 20 | 40.7 |
| 30 | 42.09 |
| 50 | 40.83 |
| 100 | 40.84 |
| 200 | 37.81 |
GRDN Fundamental Analysis
| P/E (Forward) | 30.2115 |
| P/E (Trailing) | 37.8447 |
| Market Cap ($) | 2.5 billion |
| Earnings/Share ($) | 1.03 |
| Net Profit Margin (%) | 0.045 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 1.3014 |
| EPS Estimate Next Year ($) | 1.4343 |
| WallStreet Target Price ($) | 49.86 |
| Most Recent Quarter |
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.